TPI community invites its members to a webinar by our members
When, Friday May 15, 2020 11:00AM EDT.
This webinar: Immune Engineering Human B cell-Derived Antibodies for Emerging Infectious Diseases will include the antibody maturation and methodology for selection, the impact of Teff and Treg epitopes on antibody immunogenicity, and an introduction to ISPRI, EpiVax's computational immunogenicity assessment tool used for screening biologics.
Featured speakers include Dr. Annie De Groot (CEO/CSO, EpiVax, Inc.), Dr. Brandon DeKosky, PhD (Assistant Professor, The University of Kansas), Frances Terry, MPH (Director of Analysis, EpiVax, Inc.).
Please extend this invitation to any colleagues or associates you feel would benefit from attending.
*For all who register: approximately 24 hours before the event, you will will receive a link to the online meeting host for this event.
We look forward to "seeing" you Friday May15, 2020 at 11:00AM EDT.